Safety of vaginal surgery for early-stage cervical cancer: A retrospective multicenter cohort study

Abdominal Radical hysterectomy (ARH) with pelvic lymph node assessment is considered the standard treatment for early-stage cervical cancer. Accepted routes have previously included laparoscopic or robotic approaches (LRH). Laparoscopy-assisted vaginal or vaginal radical hysterectomy (LVRH) are perf...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European journal of surgical oncology 2024-10, Vol.50 (10), p.108518, Article 108518
Hauptverfasser: Bernard, Laurence, Pond, Gregory R., Elit, Laurie, Vicus, Danielle, Piedimonte, Sabrina, Nelson, Gregg, Aubrey, Christa, Plante, Marie, Teo-Fortin, Ly-Ann, Lau, Susie, Kwon, Janice, Kim, Soyoun Rachel, Altman, Alon D., Mercier, Nora-Beth, Willows, Karla, Sadeq, Noor, Feigenberg, Tomer, Sabourin, Jeanelle, Samouelian, Vanessa, Helpman, Limor
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Abdominal Radical hysterectomy (ARH) with pelvic lymph node assessment is considered the standard treatment for early-stage cervical cancer. Accepted routes have previously included laparoscopic or robotic approaches (LRH). Laparoscopy-assisted vaginal or vaginal radical hysterectomy (LVRH) are performed in some centers. The objective of this study is to compare surgical and oncological outcomes of LVRH, to laparoscopic and abdominal approaches. A retrospective multicenter analysis of consecutive cervical cancer cases who underwent a radical hysterectomy between 2007 and 2017 in eleven regional cancer centers across Canada. A comparison of patients stratified by surgical technique was undertaken. T-test, Wilcoxon rank-sum and chi-square were used to compare patient characteristics. Log-rank tests and Cox proportional hazards models were employed to compare recurrence and survival across surgical groups. A total of 1071 patients with cervical cancer stage IA1 with lymphovascular invasion to stage IIIC (FIGO 2018)
ISSN:0748-7983
1532-2157
1532-2157
DOI:10.1016/j.ejso.2024.108518